In this article, we will take a look into Abbott Laboratories's (NYSE:ABT) DCF analysis, a reliable and data-driven approach ...

Missouri judge denies Abbott Laboratories (ABT) new trial request after $500 million infant formula case verdict.

Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BlackRock, Inc.

Abbott Laboratories' revenue and return on invested capital could be more consistent. Read why potential investors will need ...

Shares of Abbott Laboratories ABT slipped 0.14% to $117.96 Tuesday, on what proved to be an all-around great trading session ...

On Friday, Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $117.76 which represents a slight increase of $0.50 or 0.43% from the prior close of $117.26. The stock opened at $117 ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

On Thursday, Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $117.26 which represents a slight increase of $1.33 or 1.15% from the prior close of $115.93. The stock opened at ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Abbott Laboratories, Inc. ABT recently announced the first patient procedures with its investigational transcatheter aortic ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...